EBV-positive MTX-diffuse large B cell lymphoma in a rheumatoid arthritis patient. 2014

Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
Department of Radiology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan, tokuyama@oita-u.ac.jp.

Methotrexate (MTX)-associated lymphoproliferative disorders have received much attention from rheumatologists, and early diagnosis is very important for reducing mortality. There are several reports of radiologic findings in patients with pulmonary malignant lymphoma, mainly consisting of masses, nodules, and lymphadenopathy. Computed tomography has rarely detected necrosis in the masses. In this article, we report a case of MTX-associated Epstein-Barr virus-positive diffuse large B-cell lymphoma characterized by a very large lung mass with prominent areas of central necrosis. The disease regressed after withdrawal of MTX.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011856 Radiographic Image Enhancement Improvement in the quality of an x-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed. Digital Radiography,Image Enhancement, Radiographic,Radiography, Digital,Enhancement, Radiographic Image,Enhancements, Radiographic Image,Image Enhancements, Radiographic,Radiographic Image Enhancements
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
July 2013, Blood,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
December 2011, Clinical lymphoma, myeloma & leukemia,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
February 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
January 2014, International journal of clinical and experimental medicine,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
January 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
August 2020, Journal of pediatric hematology/oncology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
November 2012, BMC nephrology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
January 2022, Indian journal of pathology & microbiology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
February 2013, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Kouhei Tokuyama, and Fumito Okada, and Shunro Matsumoto, and Hiromu Mori, and Masao Ogata, and Erika Omote, and Toru Yamasaki, and Syougo Urabe
January 2019, Pathology international,
Copied contents to your clipboard!